LD-2 disclosure · 3rd Quarter - Report
CAPTURA BIOPHARMA
Coverage · No income or expenses were reported on this filing.
Client
- Description
- Captura is developing an orally administered MCM for radionuclide contamination.
- Location
- Arkansas · United States of America
Registrant
- Description
- Consulting and Government Affairs
- Location
- Huntsville, Alabama, United States of America
Lobbying activities
2 issuesDefense
FY2024/2025 NDAA; FY2024/2025 Defense Appropriations
LobbyistsJULIE LASSETER · mr DAVID FORREST LASSETER · mr STEPHEN ELLIOTT BOYD
Covered position (JULIE LASSETER): Schedule C (DoD); Congressional Staffer (U.S. House and U.S. Senate)
Covered position (mr DAVID FORREST LASSETER): Schedule C (DoD and DOJ); Congressional Staffer (U.S. House and U.S. Senate)
Covered position (mr STEPHEN ELLIOTT BOYD): Assistant Attorney General at Department of Justice; former Congressional Aide (House and Senate).
TargetedSENATE · HOUSE OF REPRESENTATIVES · Defense, Dept of (DOD) · Army, Dept of (Other)
Disaster Planning/Emergencies
FY2024/2025 NDAA; FY2024/2025 Defense Appropriations
LobbyistsJULIE LASSETER · mr DAVID FORREST LASSETER · mr STEPHEN ELLIOTT BOYD
Covered position (JULIE LASSETER): Former Schedule C (DOD), Former Congressional Aide (U.S. Senate, U.S. House)
Covered position (mr DAVID FORREST LASSETER): Former Schedule C (DOD, DOJ), Former Congressional Aide (U.S. House, U.S. Senate)
Covered position (mr STEPHEN ELLIOTT BOYD): Assistant Attorney General at Department of Justice; former Congressional Aide (U.S. House and U.S. Senate)